big pharma

Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push

Photo of author
AstraZeneca is set to invest $50 billion in the U.S., featuring a large manufacturing plant in Virginia, marking its biggest manufacturing investment. This move aligns ...